• No results found

Validation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited

N/A
N/A
Protected

Academic year: 2021

Share "Validation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

(1)

Validation Approach and Scope for

Business Process System Validation

Epitome Technologies Private Limited

(2)

Table Of Contents:

1.0 GENERAL ... 3

2.0 SCOPE – MODULES COVERED ... 3

3.0 QUALIFICATION APPROACH ... 3

3.1 APPROACH FOR IMPLEMENTED SYSTEM ... 3

4.0 MAJOR STEPS ... 3

4.1 DOCUMENT USER REQUIREMENTS SPECIFICATIONS ... 3

4.2 DEVELOP VALIDATION MASTER PLAN... 4

4.3 GAP ANALYSIS ... 4 4.4 RISK ASSESSMENT ... 4 4.5 INSTALLATION QUALIFICATION ... 4 4.6 NETWORK QUALIFICATION ... 4 4.7 OPERATIONAL QUALIFICATION ... 4 4.8 PERFORMANCE QUALIFICATION ... 4 4.9 DOCUMENTATION ... 4

5.0 GAP ANALYSIS PROCESS ... 4

5.1 PURPOSE ... 4

6.0 RISK ASSESSMENT PROCESS ... 5

6.1 RISK ASSESSMENT ASSOCIATED WITH BUSINESS PROCESS SYSTEM ... 5

7.0 SYSTEM QUALIFICATION ... 5

7.1 INSTALLATION QUALIFICATION (IQ) ... 5

7.2 NETWORK QUALIFICATION (NQ)... 5

7.3 OPERATIONAL QUALIFICATION (OQ) ... 5

7.4 PERFORMANCE QUALIFICATION (PQ) ... 6

7.5 QUALIFICATION DISCREPANCY REPORT ... 6

7.6 VALIDATION REPORT... 6

7.7 TRACEABILITY MATRIX ... 6

8.0 PARTIAL LIST OF CLIENTS... 7

(3)

1.0 GENERAL

Epitome undertakes various Computer System Validation projects in the areas of Process Control Systems, Laboratory Computerized Systems and Global Information Systems. Following GAMP guidelines, Epitome ensures compliance to major International Agencies like US FDA / MHRA / TGA etc for Computer System Validation.

This document covers an overview of “Typical Approach to Validation of Business System under use”. This will out line the scope of work, methodology, references etc.

2.0 SCOPE – MODULES COVERED

Modules generally covered for validation are given below a) Material Management

b) Quality Management

c) Production Planning Management d) Sales & Distribution Management e) Plant Maintenance Management f) Human Resources ( Part )

ERP systems being multi location / multi facility set up, it is imperative that each section handling cGMP critical transaction for regulated market is addressed in the process of computer system validation. The severity of testing and scope for complexity can be determined on the basis of criticality of each set up.

3.0 QUALIFICATION APPROACH

3.1 Approach For Implemented System

The approach generally considered for implemented Business Systems is CONCURRENT approach as the system is already under use. During the process, efforts are made to find out available information on specifications, documentation and current practices of the organization. Based on that, further activities are planned.

For every system which is implemented and under use, the model considered is SILC- Software Implemented Life Cycle based on GAMP guidelines.

Validation generally follows the steps as listed below:

4.0 MAJOR STEPS

The following para describes various activities generally covered in validation of Business Process Systems.

4.1 Document User Requirements Specifications

User Requirements document is developed as part of this validation effort. This version-controlled document formally specifies Client’s intended uses for the ERP System.

(4)

4.2 Develop Validation Master Plan

A validation master plan is developed to describe the objectives, scope, approach and responsibilities for the Business Process System validation. The validation plan gets approved before any of the protocols are approved.

4.3 GAP Analysis

GAP Analysis to be performed on the existing system validation documents, technical and design documents, required standard operating procedure and existing qualification report. On completion of the analysis any errors found in the documentation or system it should be concluded and then only further qualification activity proceed.

4.4 Risk Assessment

To identify the various risk related to cGMP to operate the Business Process System. During this activity, the system design is evaluated and if the risk cause is not considered in the design then suitable mitigation and change in the system is recommended. All risk identified during assessment process is challenged during the operation qualification.

4.5 Installation Qualification 4.6 Network QualificaTion 4.7 Operational Qualification 4.8 Performance Qualification 4.9 Documentation

On completion of ERP software system qualification, following documents are made available as an evidence of validation activity:

• Validation Master Plan. • GAP analysis report.

• Recommended action plan for serious gaps closures. • Risk assessment report.

• Installation qualification report. • Network qualification report. • Operation qualification report. • Performance qualification report. • Deviation reports.

• Qualification summary report. • Traceability Matrix.

5.0 GAP ANALYSIS PROCESS

5.1 Purpose

To identify the gaps of implemented Business Process system and IT infrastructure.

During GAP analysis, a detailed checklist is prepared for the system. Also, the Checklist is reviewed before the analysis, evaluation and observation. Following points (but not limited to) are generally covered for the preparation of checklist for GAP analysis:

(5)

• Review the validation documents for existing application software. • Review the design and technical documents.

• Review the documents for Standard operating procedures of the system. • Process GAP for individual process function wise.

• System hardware design and installation. • Network Infrastructure GAP.

As a result of this activity system gaps are identified. The gaps generally could be

- Lack of Documentation and Adequacy - Deficiency in IT Infrastructure

- cGMP definition in implementation

6.0 RISK ASSESSMENT PROCESS

The focus of the risk assessment is to assess those risks associated with the process/ operation of the system. The risk assessment process allows users to identify and minimize the impact of adverse events, while at the same time providing the necessary justification for the validation approach taken to support the system qualification.

6.1 Risk Assessment Associated With Business Process System

a. Identify GMP risk b. Identify risk scenarios c. Assess likelihood

d. Assess the severity of impact e. Assess probability of detection f. Overall priority

g. Appropriate measure for risk

7.0 SYSTEM QUALIFICATION

7.1 Installation Qualification (IQ)

IQ protocol is developed to verify and document that all critical aspects of the systems functions has been installed in accordance with the approved system specifications, manufacturer’s specifications and as-built documentation.

7.2 Network Qualification (NQ)

Network qualification (NQ) is associated with the network infrastructure of the ERP system and is carried out as part of Installation Qualification. Functions are verified to establish that the hardware and system software is installed in accordance with design and vendor/manufacturer recommended practices.

7.3 Operational Qualification (OQ)

OQ protocol is developed to verify proper system functionality with functional testing throughout all anticipated ranges and modes of operation. The operational tests are designed

(6)

to challenge and demonstrate the system’s ability to operate in accordance with the approved system functional/configuration specifications.

7.4 Performance Qualification (PQ)

PQ protocol is developed to verify proper system functionality with observation of actual performance. The performance tests are designed to challenge and demonstrate the system’s ability to perform in accordance with the approved user specifications.

7.5 Qualification Discrepancy Report

Any discrepancy noted during the execution of qualification is documented. Whenever a discrepancy is closed or justified, thereafter only the system is considered ready for the next qualification.

7.6 Validation Report

On successful completion of all qualifications, validation report is prepared. It confirms that the Business Systems is working as intended.

7.7 Traceability Matrix

A Traceability matrix is created to show logical linking between approved functions (FS and URS as available) with various qualification documents and procedures for easy maneuverability of validation documentation.

(7)

8.0 PARTIAL LIST OF CLIENTS

Epitome has successfully completed various SAP and other business systems validation projects. A partial List of clients is given below

Sr No Client Location

List of SAP Validation Projects

1 M/s Alembic Limited Vadodara

2. M/s Claris Lifesciences Limited Ahmedabad

3 M/s Intas Pharma Limited Ahmedabad

4 M/s Lupin Limited Mumbai / Mandideep / Goa Tarapur

5. M/s Medley Pharmaceuticals Limited Mumbai, Daman, Jammu

6. M/s Microlabs Limited Banglore / Goa

7. M/s Nicholas Piramal India Limited Mumbai / Pithampur / Zahirabad / Ennore

8. M/s NATCO Pharma Limited Hyderabad

9. M/s Strides Arcolab Limited Banglore 10. M/s Torrent Pharmaceuticals Limited Ahmedabad

11. M/s Wockhardt Limited Aurangabad

List of Other ERP System Validation Projects

10. M/s Alkem Limited Mumbai / Daman

11. M/s Aurobindo Pharma Limited Hyderabad 12. M/s Dishman Pharmaceuticals &

Chemicals Limited

Ahmedabad

13. M/s EIPICO ( Oracle Process Management)

Egypt

14. M/s Global Pharmatech Private Limited Banglore 15. M/s J B Chemicals & Pharmaceuticals

Limited ( J D Edwards )

Mumbai / Panoli

16. M/s Jubilant Organosys Limited Noida / Nanjungud / Roorki

17. M/s Medreich Limited Banglore

18. M/s Oman Pharmaceutical Products Llc Oman 19. M/s Plethico Pharmaceutical Limited

J D Edwards Systems

Mumbai / Indore

20. M/s Promed Exports Private Limited Delhi, Solan 21. M/s Sidmak Laboratories (India) Limited Dehradun

(8)

9.0 REFERENCES

The publication listed below form part of any project being the reference documents. Each publication shall be the latest revision and addendum in effect on the date of this proposal shall be approved for execution unless noted otherwise.

Annexure 11 EU GMP regulation for Computerised System, Eudralex Volume 4 PIC/S guide Good practices for Process Systems in Regulated “GXP” Environments

GAMP 5 Good Automated Manufacturing Practices, Version 4, Guideline document for Automated Systems from International Society of Pharmaceutical Engineering GAMP guide Good Practice Guide – Testing of GxP systems

21 CFR 210 Code of Federal Regulations; Current Good Manufacturing Practicing Manufacturing, Processing, Packing, or Holding of Drugs

21 CFR 211 Code of Federal Regulations; Current Good Manufacturing Practice for Finished Pharmaceuticals

21 CFR 11 Rule for Electronic Records and signatures

7132a.07 FDA’s Compliance Policy Guide; Process Drug Processing: Input/Output Checking

7132a.08 FDA’s Compliance Policy Guide; Process Drug Processing: Identification of Persons on batch Production and Control Records

7132a.11 FDA’s Compliance Policy Guide; Process Drug Processing: CGMP Applicability to Hardware and Software

7132a.12 FDA’s Compliance Policy Guide; Process Drug Processing: Vendor Responsibility

References

Related documents

In order to obtain a well-behaved solution to the optimal execution problem with a sensible continuous-time limit, Huberman and Stanzl (2000) modify the price impact function

After the district court ruling in Jones’ case granting summary judgment to President Clinton and prior to oral argument of the appeal, the Eighth Circuit held

FEA opposes SDG&E’s requested 3% increase in common equity because: (1) it is not in line with the average common equity ratio of 48.60% that SDG&E has actually used over

Basics of contracts in the health care sector 16. Differences to

The effect of particle Þlms on codling moth egg viability was estimated from hatching rates of larvae from eggs laid on apple leaves previously treated with particle Þlm or

The Irish revolutionary Roger Casement, executed in 1916, has spawned an army of books, articles, and news stories, more about his diaries and the authenticity controversy that

S1: Mass fraction and recovery of arsenic in BATT and MIN sample, Figure S2: The ED-XRF energy spectrum (4–14 keV) of the BATT measurement, Figure S3: The ED-XRF energy

COOK, BA, Former Staff Representative, Section of Activity Coordinators, American Health Care Association, Washington, D. CURLEY, COTA, Activities Consultant, Madison,